Jump Financial’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-154,946
Closed -$380K 2398
2025
Q4
$380K Buy
+154,946
New +$673K ﹤0.01% 1434
2025
Q1
Sell
-37,600
Closed -$280K 2015
2024
Q4
$280K Sell
37,600
-11,372
-23% -$76.1K 0.01% 1337
2024
Q3
$284K Sell
48,972
-120,228
-71% -$772K 0.01% 1334
2024
Q2
$1.13M Buy
169,200
+124,800
+281% +$1.01M 0.02% 765
2024
Q1
$579K Buy
44,400
+28,221
+174% +$376K 0.02% 1094
2023
Q4
$206K Sell
16,179
-51,311
-76% -$518K 0.01% 1544
2023
Q3
$885K Buy
67,490
+28,273
+72% +$518K 0.03% 729
2023
Q2
$1M Sell
39,217
-19,693
-33% -$508K 0.04% 677
2023
Q1
$1.48M Buy
+58,910
New +$1.38M 0.06% 457

Other funds holding TMCI

Jump Financial's TMCI Position: Q1 2026 in Review

Jump Financial sold out of Treace Medical Concepts (TMCI) in Q1 2026, closing a stake of 154,946 shares — an estimated $380K sold.

Jump Financial first reported a position in TMCI in Q1 2023 and held it in 9 quarters. The position peaked at $1.48M in Q1 2023. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • Jump Financial reported no remaining Treace Medical Concepts position as of Q1 2026 after selling out during the quarter.
  • Jump Financial sold 154,946 Treace Medical Concepts shares in Q1 2026, an estimated $380K.
  • Jump Financial first reported a position in Treace Medical Concepts in Q1 2023 and held it in 9 quarters.
  • Jump Financial's Treace Medical Concepts position peaked at $1.48M in Q1 2023.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.